JenaValve Pericardial TAVR System

DEVICE3 trials

Sponsors

JenaValve Technology, Inc.

Conditions

Aortic RegurgitationAortic Valve StenosisCardiovascular DiseasesHeart DiseasesHeart Valve DiseasesVentricular Outflow Obstruction

Unknown Phase

THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

Active, not recruitingNCT02732704

JenaValve Technology, Inc.Aortic Regurgitation

Start: 2018-04-20End: 2027-09-29Target: 100Updated: 2022-11-18

JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study

JenaValve Technology, Inc.Aortic Valve Stenosis, Cardiovascular Diseases, Heart Diseases +2

Start: 2016-10-21End: 2024-04-30Updated: 2022-11-22

First in Man Study of the JenaValve TAVI Plus System Transfemoral

TerminatedNCT02818959

JenaValve Technology, Inc.Aortic Valve Stenosis, Cardiovascular Diseases, Heart Diseases +1

Start: 2013-12-31End: 2015-05-31Updated: 2020-05-21